← Leaderboards
Ashley Melnick
University Of Michigan At Ann Arbor
$91,535
Attributed
$91,535
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $39K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$91,535 · 1
By mechanism
F31$91,535 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Xing Fan$5,437,064
- Daniel Dimaio$34,640,869
- Elizabeth Joy Brisbois$4,815,119
- Max S. Wicha$49,028,071
- Gregory Yanik$2,647,882
Others in their field
Other Emerging Leaders on “Epigenetic Process”
- Michael-Christopher Keogh · Epicypher, Inc.$20,096,362
- Barbara Halina Braffett · George Washington University$9,972,097
- Ionut Bebu · George Washington University$9,972,097
- Jennifer Cohen Price · University Of California, San Francisco$9,197,178
- Scott Topper · Broad Institute, Inc.$8,965,812
- Ruchir Shah · Sciome, Llc$7,820,780
Research focus
Epigenetic ProcessAnti-CancerAtac-SeqAcute T Cell LeukemiaBromouridine SequencingCancer TherapyCell CycleCell ProliferationAcute T-Cell Lymphoblastic Leukemia CellChip-SeqChromatinClinically RelevantClinical TrialsCofactorCombatComplexDepositionDna BindingCellsDrosophila GenusEarly Phase Clinical TrialEnhancersEnzymesFuture
Grant awards (3)
Investigating the Role of Cdc73 in T-cell Acute Lymphoblastic Leukemia (T-ALL)$14,329
F31 · FY2023 · CA · contact PI
Investigating the Role of Cdc73 in T-cell Acute Lymphoblastic Leukemia (T-ALL)$38,961
F31 · FY2022 · CA · contact PI
Investigating the Role of Cdc73 in T-cell Acute Lymphoblastic Leukemia (T-ALL)$38,245
F31 · FY2021 · CA · contact PI